PT  - JOURNAL ARTICLE
AU  - Figueira Freire, Ana Paula Coelho
AU  - de Lira, Fabio Santos
AU  - von Ah Morano, Ana Elisa
AU  - Pereira, Telmo
AU  - Silva, Manuel-João Coelho
AU  - Caseiro, Armando
AU  - Destro Christofaro, Diego Giulliano
AU  - Júnior, Osmar Marchioto
AU  - Dorneles, Gilson Pires
AU  - Pinho, Ricardo Aurino
AU  - de Alencar Silva, Bruna Spolador
TI  - ROLE OF BODY MASS AND PHYSICAL ACTIVITY IN AUTONOMIC FUNCTION MODULATION ON POST-COVID-19 CONDITION: AN OBSERVATIONAL SUBANALYSIS OF FIT-COVID STUDY
AID  - 10.1101/2021.11.17.21266473
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.11.17.21266473
4099  - http://medrxiv.org/content/early/2021/11/21/2021.11.17.21266473.short
4100  - http://medrxiv.org/content/early/2021/11/21/2021.11.17.21266473.full
AB  - The harmful effects of coronavirus disease 2019 (COVID-19) can reach the autonomic nervous system (ANS) and endothelial function. Therefore, the detrimental multiorgan effects of COVID-19 could be induced by deregulations in ANS that may persist after the acute SARS-CoV-2 infection. Additionally, investigating the differences in ANS response in overweight/obese, and physically inactive participants who had COVID-19 compared to those who did not have the disease is necessary. The aim of the study was to analyze the autonomic function of young adults after mild-to-moderate infection with COVID-19 and to assess whether body mass index (BMI) and levels of physical activity modulates autonomic function in participants with and without COVID-19. Patients previously infected with COVID-19 and healthy controls were recruited for this cross-sectional observational study. A general anamnesis was taken and BMI and physical activity levels were assessed. The ANS was evaluated through heart rate variability. A total of 57 subjects were evaluated. Sympathetic nervous system activity in post-COVID-19 group was increased (stress index; p=0.0273). They also presented lower values of parasympathetic activity (p<0.05). Overweight/obese subjects in the post-COVID-19 group presented significantly lower parasympathetic activity and reduced global variability compared to non-obese in control group (p<0.05). Physically inactive subjects in post-COVID-19 group presented significantly higher sympathetic activity than active subjects in control group. Parasympathetic activity was significantly increased in physically active subjects in control group compared to the physically inactive post-COVID-19 group (p<0.05). COVID-19 promotes changes in the ANS of young adults, and these changes are modulated by Overweight/obesity and physical activity levels.Key Points‐ Our main finding is that even in mild and moderate infections, young adults who had COVID-19 had greater sympathetic activity, less parasympathetic activity, and global variability when compared to uninfected individuals.‐ In participants who were overweight and obese and/or physically inactive, cardiac autonomic modulation showed worse indices.‐ Our study provides new insights regarding the role of body mass index and physical activity status on post-COVID-19 infection autonomic deregulation that may contribute to the understand of pathophysiology and treatment of of post-acute sequelae SARS-CoV-2 infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNational Council for Scientific and Technological Development (CNPq)-Brazil and the Coordination for the Improvement of Higher Education Personnel (CAPES)-Brazil (code 001). FSL was granted a research scholarship (PQ2) from the CNPq.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical Institutional Review Board of Universidade Estadual Paulista approved the study (approval number: 38701820.0.0000.5402).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at Mendeley Data, V1, doi: 10.17632/t45r8yd6jd.1 https://doi.org/10.17632/t45r8yd6jd.1